Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

MDGL

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals is an innovative clinical-stage biopharmaceutical company with a clear goal: find a viable treatment for non-alcoholic steatohepatitis (NASH) in the United States. With its...

Madrigal Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

MNPR

Monopar Therapeutics Inc.

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company based in Wilmette, Illinois, is leading the charge in developing innovative cancer therapeutics in the United States. The compa...

Monopar Therapeutics Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

AKRO

Akero Therapeutics, Inc.

Akero Therapeutics, Inc. is a clinical-stage company dedicated to developing life-changing treatments for individuals suffering from serious metabolic diseases. Of particular focus is non-alcoholic...

Akero Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

MVF

Monash IVF Group Ltd

BlackRock, Inc. has recently launched its closed-ended fixed income mutual fund, BlackRock MuniVest Fund, Inc. The fund is managed by BlackRock Advisors, LLC and focuses on the fixed income markets...

Monash IVF Group Ltd Annual Report 2023

Healthcare Biotechnology ASX 201-500

INCY

Incyte

Wilmington-based biopharmaceutical firm, Incyte Corporation, is making waves in the hematology/oncology, and inflammation and autoimmunity space. The company has a range of clinically-proven produc...

Incyte Annual Report 2023

Healthcare Biotechnology NASDAQ 501-1000

ETON

Eton Pharmaceuticals

Deer Park, Illinois-based Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company with a focus on developing, acquiring, and commercializing pharmaceutical products for rare diseases. Its ...

Eton Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

GSS

Genetic Signatures Limited

Genetic Signatures Limited is a molecular diagnostic company that offers real-time polymerase chain reaction-based products to detect infectious diseases under the brand EasyScreen. The Australian ...

Genetic Signatures Limited Annual Report 2023

Healthcare Biotechnology ASX 51-200

ANIP

ANI Pharmaceuticals

Minnesota-based biopharmaceutical company ANI Pharmaceuticals, Inc. is gaining traction in the US and Canadian markets with its focus on branded and generic prescription pharmaceuticals. The compan...

ANI Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

MSB

Mesoblast

New York-based Mesabi Trust, a royalty trust, has been actively involved in the iron ore mining business in the United States since its inception in 1961. The company has managed to establish a sig...

Mesoblast Annual Report 2023

Healthcare Biotechnology ASX 51-200

CYDY

CytoDyn Inc

CytoDyn Inc. - a clinical-stage biotechnology company- is leading the way in developing innovative treatments for a range of therapeutic indications. The company's primary focus is on utilizing its...

CytoDyn Inc Annual Report 2023

Healthcare Biotechnology OTC 11-50

CDMO

Avid Bioservices

Avid Bioservices Inc., a leading contract development and manufacturing organization, is committed to providing top-quality process development and current good manufacturing practices (CGMP) clini...

Avid Bioservices Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

LMNL

Liminal BioSciences

Liminal BioSciences Inc., a biopharmaceutical company in its developmental stages, has set its sights on novel treatments for inflammatory, fibrotic, and metabolic diseases in Canada and the United...

Liminal BioSciences Annual Report 2021

Healthcare Biotechnology TSX 201-500

DCPH

Deciphera Pharmaceuticals

Deciphera Pharmaceuticals, Inc. - a prominent biopharmaceutical firm - has been actively involved in the discovery, development, and commercialization of innovative medicines to enhance the quality...

Deciphera Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 201-500

REGN

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. is a global leader in the discovery, invention, development, manufacturing, and commercialization of medicines to treat various diseases. Headquartered in Tarrytown,...

Regeneron Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 5001-10,000

SRRA

Sierra Oncology, Inc.

Sierra Oncology is a pharmaceutical company that is dedicated to developing and bringing to market the drug momelotinib. This drug is designed to inhibit JAK1, JAK2 & ACVR1, which could potentially...

Sierra Oncology, Inc. Annual Report 2020

Healthcare Biotechnology NASDAQ 51-200